Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
111 hedge funds and large institutions have $274M invested in Surmodics in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 10 closing their positions.
18% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 34
0.26% more ownership
Funds ownership: 85.49% → 85.75% (+0.26%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
4% less funds holding
Funds holding: 116 → 111 (-5)
5% less capital invested
Capital invested by funds: $288M → $274M (-$14.5M)
43% less call options, than puts
Call options by funds: $491K | Put options by funds: $864K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$40.9M |
| 2 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$9.02M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.82M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.31M |
| 5 |
RA
Royce & Associates
New York
|
+$980K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$5.84M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.42M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.08M |
| 4 |
AG
Algert Global
San Francisco,
California
|
-$1.22M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.18M |
SRDX Hedge Fund Activity: Q1 2017 in Review
111 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q1 2017, worth a combined $274M — down 5% from $288M a quarter earlier.
Fund positioning in SRDX was balanced in Q1 2017: 10 funds opened new positions, 10 closed out, 40 added to existing stakes and 34 trimmed.
The largest buyer was BlackRock, adding an estimated $40.9M. The largest seller was JP Morgan Chase, cutting an estimated $5.84M.
- 111 institutional investors held Surmodics (SRDX) as of Q1 2017, down from 116 in Q4 2016.
- Funds reported $274M of Surmodics stock for Q1 2017, down 5% quarter-over-quarter.
- 10 funds opened new Surmodics positions in Q1 2017 and 10 closed out, a net change of 0 holders.
- The largest Surmodics buyer in Q1 2017 was BlackRock, an estimated $40.9M added.
- The largest Surmodics seller in Q1 2017 was JP Morgan Chase, an estimated $5.84M sold.
Based on aggregated 13F filings for Q1 2017.